INS and type 1 diabetes mellitus: Such a therapy could be tested initially in newly diagnosed patients, many of whom retain sufficient insulin production to prevent diabetic complications [51,52], and, if successful, lead to the treatment of autoimmunity to prevent the metabolic diagnosis of T1D.